Skip to main content
. 2022 Mar 30;62(5):ezac154. doi: 10.1093/ejcts/ezac154

Table 1:

Patient characteristics

Characteristics No. (%)/median (IQR)
Age at surgery, years 62 (53.00–67.00)
Gender
 Male 134(48.70)
 Female 141(51.30)
BMI (kg/m2) 24.11(21.78-25.95)
Smoker 88(32.00)
Hypertension 107(38.9)
Diabetes mellitus 38(13.8)
Coronary artery disease 21(7.6)
Cerebrovascular disease 18(6.5)
Laterality
 Right upper lobe 95(34.5)
 Right middle lobe 28(10.2)
 Right lower lobe 55(20.0)
 Left upper lobe 49(17.8)
 Left lower lobe 48(17.5)
Clinical stage
 IA1 19(6.9)
 IA2 96(34.9)
 IA3 70(25.5)
 IB 41(14.9)
 IIA 14(5.1)
 IIB 9(3.3)
 IIIA 19(6.9)
 IIIB 3(1.1)
Clinical T stage
 T1a 18(6.5)
 T1b 96(34.9)
 T1c 77(28.0)
 T2a 54(19.6)
 T2b 16(5.8)
 T3 11(0.0)
 T4 1(0.4)
Clinical N stage
 N0 245(89.1)
 N1 8(2.9)
 N2 18(6.5)
Bleeding volume 30(20-50)
Immediate postoperative air-leakage 128(46.5)
Surgery duration, min 109.70(90.25-137.96)
SumPBP 1016.24 (704.98-1787.41)
SumPBP-Flushing 73.92(39.51-141.61)
Drainage volume (ml) 410(275-750)
Prolonged tube indwelling duration 38(13.8)
Histological subtype
 Adenocarcinoma 224(81.5)
 Squamous 23(8.4)
 Large cell, mixed, other 28(10.2)

N = 275.

BMI: body mass index; IQR: interquartile range; PBP: proportion of blood pixels; SumPBP: sum of PBP; SumPBP-Flushing: sum of PBP from flushing to the end of the operation.